Cascade biomimetic intelligent nanotheranostic agents for imaging-guided tumor synergistic therapy

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Chen Q, Liang C, Wang C et al. An imagable and photothermal “Abraxane-like” nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors. Adv. Mater. 27(5), 903–910 (2015).
  Medline CASGoogle Scholar
• 2. Twelves C, Wong A, Nowacki MP et al. Capecitabine as adjuvant treatment for stage III colon cancer. New. Engl. J. Med. 352(26), 2696–2704 (2005).
  Medline CASGoogle Scholar
• 3. Yang XT, Tang Q, Jiang Y et al. Nanoscale ATP-responsive zeolitic imidazole framework - 90 as a general platform for cytosolic protein delivery and genome editing. J. Am. Chem. Soc. 141(9), 3782–3786 (2019).
  Medline CASGoogle Scholar
• 4. Ding YP, Su SS, Zhang RR et al. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures. Biomaterials 113, 243–252 (2017).
  Medline CASGoogle Scholar
• 5. Tian XT, Cao PP, Zhang H et al. GSH-activated MRI-guided enhanced photodynamic- and chemo-combination therapy with a MnO₂-coated porphyrin metal organic framework. Chem. Commun. 55(44), 6241–6244 (2019).
  Medline CASGoogle Scholar
• 6. Wang HY, Pan XT, Wang XT et al. Degradable carbon-silica nanocomposite with immunoadjuvant property for dual-modality photothermal/photodynamic therapy. ACS Nano 14(3), 2847–2859 (2020).
  Medline CASGoogle Scholar
• 7. Liu YJ, Bhattarai P, Dai ZF et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem. Soc. Rev. 48(7), 2053–2108 (2019).
  Medline CASGoogle Scholar
• 8. Wang S, Mao JJ, Liu H et al. pH-sensitive nanotheranostics for dual-modality imaging guided nanoenzyme catalysis therapy and phototherapy. J. Mater. Chem. B 8(22), 4859–4869 (2020).
  Medline CASGoogle Scholar
• 9. Ahmad A, Gupta A, Ansari MM et al. Hyperbranched polymer-functionalized magnetic nanoparticle-mediated hyperthermia and niclosamide bimodal therapy of colorectal cancer cells. ACS. Biomater. Sci. Eng. 6(2), 1102–1111 (2020).
  Medline CASGoogle Scholar
• 10. Ighani A, Partridge ACR, Shear NH et al. Comparison of management guidelines for moderate-to-severe plaque psoriasis: a review of phototherapy, systemic therapies, and biologic agents. J. Cutan. Med. Surg. 23(2), 204–221 (2019).
  MedlineGoogle Scholar
• 11. Wu WB, Mao D, Hu F et al. A highly efficient and photostable photosensitizer with near-infrared aggregation-induced emission for image-guided photodynamic anticancer therapy. Adv. Mater. 29(33), 1–10 (2017).
  CASGoogle Scholar
• 12. Yang Y, Wang L, Cao HQ et al. Photodynamic therapy with liposomes encapsulating photosensitizers with aggregation-induced emission. Nano Lett. 19(3), 1821–1826 (2019).
  Medline CASGoogle Scholar
• 13. Singh S, Aggarwal A, Bhupathiraju NVA et al. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics. Chem. Rev. 115(18), 10261–10306 (2015).
  Medline CASGoogle Scholar
• 14. Zhou J, Li MH, Hou YH et al. Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy. ACS Nano 12(3), 2858–2872 (2018).
  Medline CASGoogle Scholar
• 15. Liu Z, Robinson JT, Sun XM et al. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130(33), 10876–10877 (2008).
  Medline CASGoogle Scholar
• 16. Sun XM, Liu Z, Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1(3), 203–212 (2008).
  Medline CASGoogle Scholar
• 17. Zhang W, Guo ZY, Huang DQ et al. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 32(33), 8555–8561 (2011).
  Medline CASGoogle Scholar
• 18. Cho Y, Choi Y. Graphene oxide–photosensitizer conjugate as a redox-responsive theranostic agent. Chem. Commun. 48(79), 9912–9914 (2012). • Graphene oxide has fluorescence-quenching properties for photosensitizers.
  Medline CASGoogle Scholar
• 19. Kim H, Kim S, Park C et al. Glutathione-induced intracellular release of guests from mesoporous silica nanocontainers with cyclodextrin gatekeepers. Adv. Mater. 22(38), 4280–4283 (2010).
  Medline CASGoogle Scholar
• 20. Guo Y, Zhang X, Wu FG. A graphene oxide-based switch-on fluorescent probe for glutathione detection and cancer diagnosis. J. Colloid Interface Sci. 530(15), 511–520 (2018). • Reduced glutathione can reduce the entry of graphene oxide (GO) into reduced GO and guide the release of drugs from the surface of GO, which gave the authors inspiration to develop comprehensive reagents for precise treatment of tumors.
  Medline CASGoogle Scholar
• 21. He Z, Dai Y, Li X et al. Hybrid nanomedicine fabricated from photosensitizer-terminated metal-organic framework nanoparticles for photodynamic therapy and hypoxia-activated cascade chemotherapy. Small 15(4), e1804131 (2019).
  MedlineGoogle Scholar
• 22. Pei Q, Hu X, Zheng X et al. Light-activatable red blood cell membrane-camouflaged dimeric prodrug nanoparticles for synergistic photodynamic/chemotherapy. ACS Nano 12(2), 1630–1641 (2018).
  Medline CASGoogle Scholar
• 23. Park JH, Mohapatra A, Zhou J et al. Virus-mimicking cell membrane-coated nanoparticles for cytosolic delivery of mRNA. Angew. Chem. Int. Ed. Engl. 61(2), e202113671 (2022).
  Medline CASGoogle Scholar
• 24. Qu Y, Chu B, Wei X et al. Cancer-cell-biomimetic nanoparticles for targeted therapy of multiple myeloma based on bone marrow homing. Adv. Mater. 34(46), e2107883 (2021).
  Google Scholar
• 25. Villa CH, Anselmo AC, Mitragotri S et al. Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems. Adv. Drug. Deliv. Rev. 106(15), 88–103 (2016).
  Medline CASGoogle Scholar
• 26. Li S-Y, Cheng H, Qiu W-X et al. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials 142, 149–161 (2017).
  Medline CASGoogle Scholar
• 27. Fang ZZ, Yang EL, Du Y et al. Biomimetic smart nanoplatform for dual imaging-guided synergistic cancer therapy. J. Mater. Chem. B 10(6), 966–976 (2022). •• Folic acid-functionalized red blood cell membrane can give the nanoplatform longer blood circulation, avoid being cleared by the body's immune system and be delivered to tumor tissues accurately.
  Medline CASGoogle Scholar
• 28. Liu W, Yan Q, Xia C et al. Recent advances in cell membrane coated metal-organic frameworks (MOFs) for tumor therapy. J. Mater. Chem. B 9(22), 4459–4474 (2021).
  Medline CASGoogle Scholar
• 29. Zhang W, Yu Z-L, Wu M et al. Magnetic and folate functionalization enables rapid isolation and enhanced tumor-targeting of cell-derived microvesicles. ACS Nano 11(1), 277–290 (2017).
  Medline CASGoogle Scholar
• 30. Fan Z, Li P-Y, Deng J et al. Cell membrane coating for reducing nanoparticle-induced inflammatory responses to scaffold constructs. Nano Res. 11(10), 5573–5583 (2018).
  Medline CASGoogle Scholar
• 31. Wan S-S, Cheng Q, Zeng X et al. A Mn(III)-sealed metal-organic framework nanosystem for redox-unlocked tumor theranostics. ACS Nano 13(6), 6561–6571 (2019).
  Medline CASGoogle Scholar
• 32. Bian B, Liu Q, Yu S. Peroxidase mimetic activity of porphyrin modified ZnFe₂O₄/reduced graphene oxide and its application for colorimetric detection of H₂O₂ and glutathione. Colloids Surf. B Biointerfaces 181, 567–575 (2019).
  Medline CASGoogle Scholar
• 33. Li Y, Zhou J, Wang L et al. Endogenous hydrogen sulfide-triggered MOF-based nanoenzyme for synergic cancer therapy. ACS Appl. Mater. Interfaces 12(27), 30213–30220 (2020).
  Medline CASGoogle Scholar
• 34. Zhang L, Zhang J, Xu L et al. NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses. J. Nanobiotechnol. 19(1), 142 (2021).
  Medline CASGoogle Scholar
• 35. Li XY, Ji Q, Yan C et al. H₂O₂/pH dual-responsive biomimetic nanoenzyme drugs delivery system for enhanced tumor photodynamic therapy. Nanoscale Res. Lett. 17(1), 103–113 (2022). • MnO2 shell has catalase-like activity and can react with excessive H2O2 in the tumor microenvironment to supply more O2 to enhance subsequent photodynamic therapy.
  Medline CASGoogle Scholar
• 36. Yu Z, Pan W, Li N et al. A nuclear targeted dual-photosensitizer for drug-resistant cancer therapy with NIR activated multiple ROS. Chem. Sci. 7(7), 4237–4244 (2016).
  Medline CASGoogle Scholar
• 37. Ren W, Yan Y, Zeng L et al. A near infrared light triggered hydrogenated black TiO₂ for cancer photothermal therapy. Adv. Healthc. Mater. 4(10), 1526–1536 (2015).
  Medline CASGoogle Scholar
• 38. Bai J, Jia X, Zhen W et al. A facile ion-doping strategy to regulate tumor microenvironments for enhanced multimodal tumor theranostics. J. Am. Chem. Soc. 140(1), 106–109 (2018).
  Medline CASGoogle Scholar
• 39. Zeng F, Qin H, Liu L et al. Photoacoustic-immune therapy with a multi-purpose black phosphorus-based nanoparticle. Nano Res. 13(12), 1–13 (2020).
  Google Scholar
• 40. Zhang Z, Ni D, Wang F et al. In vitro study of enhanced photodynamic cancer cell killing effect by nanometer-thick gold nanosheets. Nano Res. 13, 3217–3223 (2020).
  Medline CASGoogle Scholar
• 41. Wang Z, Jia T, Sun Q et al. Construction of bi/phthalocyanine manganese nanocomposite for trimodal imaging directed photodynamic and photothermal therapy mediated by 808nm light. Biomaterials 228, 119569 (2020).
  Medline CASGoogle Scholar
• 42. Liang X, Ye X, Wang C et al. Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J. Control. Rel. 296, 150–161 (2019).
  Medline CASGoogle Scholar
• 43. Chelora J, Liang Y, Wei W-C et al. Single molecular nanomedicine with NIR light-initiated superoxide radical, singlet oxygen and thermal generation for hypoxia-overcoming cancer therapy. Nanoscale 13(17), 8012–8016 (2021).
  Medline CASGoogle Scholar
• 44. Chen W-H, Luo G-F, Lei Q et al. Rational design of multifunctional magnetic mesoporous silica nanoparticle for tumor-targeted magnetic resonance imaging and precise therapy. Biomaterials 76(20), 87–101 (2016).
  Medline CASGoogle Scholar
• 45. Liu B, Hu F, Zhang J et al. A biomimetic coordination nanoplatform for controlled encapsulation and delivery of drug–gene combinations. Angew. Chem. Int. Ed. Engl. 58(26), 8804–8808 (2019).
  Medline CASGoogle Scholar
• 46. Zou Q, Huang J, Zhang X. One-step synthesis of iodinated polypyrrole nanoparticles for CT imaging guided photothermal therapy of tumors. Small 14(45), e1803101 (2018).
  MedlineGoogle Scholar
• 47. Li L, Zhang Q, She Y-C et al. High-efficiency degradation of bisphenol A by heterogeneous Mn-Fe layered double oxides through peroxymonosulfate activation: performance and synergetic mechanism. Sep. Purif. Technol. 270(3), 1–3 (2021).
  Google Scholar
• 48. Huang H, Zhang C, Wang X et al. Overcoming hypoxia-restrained radiotherapy using an erythrocyte-inspired and glucose-activatable platform. Nano Lett. 20(6), 4211–4219 (2020).
  Medline CASGoogle Scholar
• 49. Ma BJ, Guo S, Nishina Y et al. Reaction between graphene oxide and intracellular glutathione affects cell viability and proliferation. ACS Appl. Mater. Interfaces 13(3), 3528–3535 (2021).
  Medline CASGoogle Scholar
• 50. Moon IK, Lee J, Ruoff RS et al. Reduced graphene oxide by chemical graphitization. Nat. Commun. 1, 73 (2010).
  MedlineGoogle Scholar
• 51. Yan M, Liu Y, Zhu X et al. Nanoscale reduced graphene oxide-mediated photothermal therapy together with IDO inhibition and PD-L1 blockade synergistically promote antitumor immunity. ACS Appl. Mater. Interfaces 11(2), 1876–1885 (2019).
  Medline CASGoogle Scholar
• 52. Ye S, Wang F, Fan Z et al. Light/pH-triggered biomimetic red blood cell membranes camouflaged small molecular drug assemblies for imaging-guided combinational chemo-photothermal therapy. ACS Appl. Mater. Interfaces 11(17), 15262–15275 (2019).
  Medline CASGoogle Scholar
• 53. Tian Q, Jiang F, Zou R et al. Hydrophilic Cu₉S₅ nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo. ACS Nano 5(12), 9761–9771 (2011).
  Medline CASGoogle Scholar
• 54. Hessel C-M, Pattani V-P, Rasch M et al. Copper selenide nanocrystals for photothermal therapy. Nano Lett. 11(6), 2560–2566 (2011).
  Medline CASGoogle Scholar
• 55. Yong Y, Zhou L, Gu Z et al. WS₂ nanosheet as a new photosensitizer carrier for combined photodynamic and photothermal therapy of cancer cells. Nanoscale 6(17), 10394–10403 (2014).
  Medline CASGoogle Scholar
• 56. Min H, Wang J, Qi Y et al. Biomimetic metal-organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy. Adv. Mater. 31(15), e1808200 (2019).
  MedlineGoogle Scholar
• 57. Hou M, Liu W, Zhang L et al. Responsive agarose hydrogel incorporated with natural humic acid and MnO₂ nanoparticles for effective relief of tumor hypoxia and enhanced photo-induced tumor therapy. Biomater. Sci. 8(1), 353–369 (2020).
  Medline CASGoogle Scholar
• 58. Chen Z, Ji H, Liu C et al. A multinuclear metal complex based DNase-mimetic artificial enzyme: matrix cleavage for combating bacterial biofilms. Angew. Chem. Int. Ed. Engl. 55(36), 10732–10736 (2016).
  Medline CASGoogle Scholar
• 59. Sun Q, Bi H, Wang Z et al. O₂-generating metal-organic framework-based hydrophobic photosensitizer delivery system for enhanced photodynamic therapy. ACS Appl. Mater. Interfaces 11(40), 36347–36358 (2019).
  Medline CASGoogle Scholar
• 60. Wang X-H, Yu Y-X, Cheng K et al. Polylysine modified conjugated polymer nanoparticles loaded with the singlet oxygen probe 1,3-diphenylisobenzofuran and the photosensitizer indocyanine green for use in fluorometric sensing and in photodynamic therapy. Mikrochim. Acta 186(12), 842 (2019).
  Medline CASGoogle Scholar
• 61. Aranda A, Sequedo L, Tolosa L et al. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol. In Vitro 27(2), 954–963 (2013).
  Medline CASGoogle Scholar
• 62. Yu Z, Lou R, Pan W et al. Nanoenzymes in disease diagnosis and therapy. Chem. Commun. 56(99), 15513–15524 (2020).
  Medline CASGoogle Scholar
• 63. Lin LS, Song JB, Song L et al. Simultaneous Fenton-like ion delivery and glutathione depletion by MnO₂-based nanoagent to enhance chemodynamic therapy. Angew. Chem. Int. Ed. 57(18), 4902–4906 (2018). •• MnO2 not only has nuclear magnetic imaging ability, which can real-time monitor the distribution of nanoplatform in the body, but also can initiate Fenton-like activity to generate hydroxyl radical (.OH) from H2O2.
  Medline CASGoogle Scholar
• 64. Ding B, Zheng P, Jiang F et al. MnOx nanospikes as nanoadjuvants and immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect. Angew. Chem. Int. Ed. Engl. 59(38), 16381–16384 (2020).
  Medline CASGoogle Scholar
• 65. Gao W, Hu C-M, Fang R-H et al. Surface functionalization of gold nanoparticles with red blood cell membranes. Adv. Mater. 25(26), 3549–3553 (2013).
  Medline CASGoogle Scholar
• 66. Ding H, Lv Y, Ni D et al. Erythrocyte membrane-coated NIR-triggered biomimetic nanovectors with programmed delivery for photodynamic therapy of cancer. Nanoscale 7(21), 9806–9815 (2015).
  Medline CASGoogle Scholar